Skip to content

XORTX
  • About
    • Management Team
    • Board of Directors
    • Advisory Board
  • Pipeline
    • Coronavirus – COVID-19 Program
    • Autosomal Dominant Polycystic Kidney Disease
    • Diabetic Nephropathy
  • Strategic Partnerships
  • Investors
    • Press Releases
    • Presentations
    • Media
    • Independent Research
    • Financials
    • SEDAR
    • Transfer Agent
    • Upcoming Events
  • Contact
Site Search

Upcoming Events

Annual and Special Meeting of Shareholders – Friday, October 23, 2020

  • Notice of Meeting
  • Form of Proxy
  • Management Information Circular

Please subscribe to our email newsletter to receive notifications of announcements, news and events.

Leave a Reply Cancel reply

You must be logged in to post a comment.

Press Releases

  • XORTX Announces Topline Results from Mount Sinai’s COVID-19 Clinical Study November 16, 2020
  • XORTX Participation in Virtual Conferences October 28, 2020
  • XORTX Reports Annual & Special Meeting Results October 23, 2020
  • XORTX Receives Positive Feedback from FDA on COVID-19 Related Acute Kidney Injury October 8, 2020
  • XORTX Highlights New Studies of Acute Kidney Disease Due to COVID-19 Infection September 15, 2020
XORTX Therapeutics Inc.
4000, 421 7th Avenue SW
Calgary, Alberta T2P 4K9
Ph: +1 (403) 455-7727
info@xortx.com
Theme by Colorlib Powered by WordPress